Respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and sleep-related breathing disorders often require long-term or intermittent oxygen supplementation. As healthcare systems shift their focus toward effective chronic disease management, the demand for reliable oxygen therapy equipment continues to rise steadily.
The oxygen therapy equipment market size is expected to reach US$ 5.6 billion by 2031, growing at a CAGR of 6.5% during 2025–2031. This growth reflects the increasing number of patients requiring long-term oxygen therapy, particularly among aging populations and individuals with lifestyle-related respiratory conditions.
Chronic disease management programs emphasize continuity of care, which has significantly increased the adoption of home-based oxygen therapy. Patients with COPD and other chronic respiratory disorders benefit from continuous oxygen delivery that improves oxygen saturation, reduces hospitalization rates, and enhances overall quality of life. As a result, compact and easy-to-use oxygen concentrators have become a preferred choice for both patients and healthcare providers.
Leading manufacturers are focusing on solutions that address the needs of long-term care patients. Inogen and Invacare Corporation have established strong positions in the portable oxygen concentrator segment, offering devices that combine mobility, durability, and energy efficiency. These solutions allow patients to maintain independence while adhering to prescribed oxygen therapy regimens.
Hospital and clinical environments continue to rely heavily on oxygen therapy equipment for chronic disease stabilization and acute exacerbations. Smiths Medical and Teleflex Incorporated supply oxygen delivery and respiratory support systems used extensively in emergency rooms, intensive care units, and respiratory wards. Their products are designed to meet strict clinical performance and regulatory standards.
Medical oxygen suppliers also play a critical role in chronic disease care. Linde Healthcare provides integrated oxygen supply solutions that support both hospital infrastructure and homecare settings. Additionally, companies such as Sunset Healthcare Solutions Inc. and Care Enterprise Co., Ltd. supply essential accessories that enhance patient comfort and therapy compliance.
From a regional perspective, North America leads the market due to advanced chronic care programs and favorable reimbursement policies. Europe follows with strong adoption of long-term oxygen therapy, while Asia-Pacific is emerging rapidly as healthcare access improves and respiratory disease awareness increases.
In summary, chronic disease management is a central driver of the oxygen therapy equipment market. As healthcare systems prioritize long-term patient outcomes, demand for advanced and patient-friendly oxygen therapy solutions will continue to expand through 2031.
Related Reports –
Hyperbaric Oxygen Therapy Devices Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Therapeutic Respiratory Devices Market Key Players Analysis, Opportunities, and Growth Forecast by 2031
Respiratory Care Devices Market Trends and Analysis by 2031
About Us –
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Information
Website: theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
